Fundraising Fox
AI VIVO
4 known investors
Find your way into AI VIVO
Sign up to see every warm intro you have to AI VIVO
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AI VIVO team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
Founders & leadership
PG
Peyman GifaniFounderHe brings expertise in systems pharmacology, systems biology, synthetic biology, nonlinear dynamics, and machine learning applications to pharmaceutical development.
Investors · 4
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: DCVC (Data Collective)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
EMV Capitallisted by EMV CapitalLondon
How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- AIVIVO LTD
- Company number
- 10694447
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 28 Mar 2017
- Registered office
- 25 Bioinnovation Centre, Cambridge Science Park, Milton, Cambridge, England, CB4 0FW
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology74909 — Other professional, scientific and technical activities n.e.c.
- Accounts
- last made up to 31 Mar 2026 · next due 31 Dec 2027
- Confirmation statement
- last made up to 27 Mar 2026 · next due 10 Apr 2027
Current officers · 3
- Matthew Gregory Richard Cleevely — director, appointed 10 Oct 2019
- Peyman Gifani — director, appointed 28 Mar 2017
- Mehdi Shahidi — director, appointed 29 Oct 2019
Source: Companies House public register · retrieved 3 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does AI VIVO do?
- AIVIVO develops drug discovery solutions at the organism level, focusing on accelerating pharmaceutical development processes.
- Who founded AI VIVO?
- AI VIVO was founded by Peyman Gifani.
- Who are AI VIVO's investors?
- AI VIVO's investors include DCVC (Data Collective), EMV Capital, Manta Ray Ventures, Martlet Capital.